 Multiple-dose, open-label, single-period study consisting of three consecutive phases: Phase A - run-in warfarin dose-finding phase Phase B - warfarin pharmacokinetics PK and international normalised ratio INR profiling Phase C - warfarin alone at their individualised doses 